Alert: The Plaza Building will remain closed through Jan. 20, 2025.
The Plaza Building will remain closed through Jan. 20, 2025. The Health Center is operating in a modified capacity. Call 303-615-9999 for appointment information during operating hours. Reminder, the Health Center is closed for the winter break Dec. 24 - Jan. 1.
Learn More
Volume 3, Issue 19 | October 18, 2023
Featured Recruitment Studies
Is this Study for You?
Birth Control Hormonal Injection/Shot Study
This study is studying levonorgestrel butanoate (LB) as a possible long-acting and reversible injectable formulation for female contraception.
Are these Studies for You?
Pre-IVF Treatment with a GnRH Antagonist in Women with Endometriosis - A Prospective Double-blind Placebo-controlled Trial
Do you or somebody you know suffer from endometriosis who is also considering IVF treatment? This study seeks to investigate the impacts of Orilissa on IVF treatment, especially regarding embryo transfer. Patients aged 18-40 with an endometriosis diagnosis may be eligible to participate in this study!
IMPAACT 2021 RSV Vaccine Study
We are looking for volunteers to participate in a research study to receive a vaccine or placebo to help researchers learn more about how to prevent Respiratory Syncytial Virus (RSV) illness in infants and children. Your child can participate if they have a healthy immune system and have never had an illness caused by RSV.
- The study lasts 6 to 10 months
- Vaccine is given as nasal drops
- You will be compensated for your time
-tmb-0.tmb-image350.png?Culture=en&sfvrsn=92130abb_1 "MitoQ Supplementation for Restoring Aerobic Exercise Training Effects on Endothelial Function in Postmenopausal Women")
MitoQ Supplementation for Restoring Aerobic Exercise Training Effects on Endothelial Function in Postmenopausal Women
We are recruiting postmenopausal women to participate in a research study to help us understand if we can improve exercise training benefits on cardiovascular health by administering an antioxidant supplement.
Prolonged Sedentary Behavior in Older Women with and without Type 2 Diabetes: Knowledge, Engagement, and Relationship to Cardiometabolic Risk (SitWise Study)
We are searching for women with Type 2 Diabetes to participate in a study that plans to learn more about how time spent sitting influences cardiovascular and muscle health. You may be eligible if you:
- are between the ages of 60-75 years
- are not prescribed insulin
- do not smoke
- currently do not participate in a regular exercise program
Does When You Exercise Matter? A Randomized Trial Comparing the Effect of Morning versus Evening Aerobic Exercise on Weight Loss and Compensatory Behaviors
Generally, healthy adults who have a BMI of 25-40 are invited to participate in an exercise research study. Help us find out the different effects of morning and nighttime exercise!
Evaluation of Clinical Effectiveness, Cost, and Implementation Factors to Optimize Scalability of Treatment for Co-Occurring SUD and PTSD Among Teens
The Department of Psychiatry at the University of Colorado School of Medicine is conducting a research study to evaluate treatment options for adolescents with co-occurring trauma and substance use. This study aims to compare two evidence-based and integrative treatments, Risk Reduction Through Family Therapy (RRFT) and Encompass. Participation in this study includes approximately 18 treatment sessions and 4 research visits. Compensation provided.
You may be eligible or your teen may be eligible if they are:
You may be eligible or your teen may be eligible if they are:
- 13-18 years old
- Have experienced a traumatic event
- Have used substances including marijuana, alcohol, or other drugs in the past month
- Willing to allow a caregiver to participate
A Phase 3, Single Arm, Open Label Study to Evaluate the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women with Uterine Fibroids or Endometriosis Who are 18 to 50 Years of Age and at Risk of Pregnancy
To assess the safety and contraceptive effectiveness of a combination medication of Myfembree and birth control.
Women volunteers that have endometriosis or fibroids are needed for us to learn more about the effects of a combination therapy containing Myfembree (relugolix) and a birth control medication.
Participants will have:
Women volunteers that have endometriosis or fibroids are needed for us to learn more about the effects of a combination therapy containing Myfembree (relugolix) and a birth control medication.
Participants will have:
- Endometriosis or Fibroids
- Aged 18-49 years old
- Have regular menstrual cycles
- Be at risk of pregnancy
- Be able and willing to complete a daily electronic diary (provided)
Main Procedures Involved:
- 11 study visits over 2 years
- History & Physical
- Study Medication provided for approximately 1 year
- Dexa exams to look at bone density
- Surveys on an electronic diary
Duration of Participation:
1 year of active study participation and 1 year of follow-up
1 year of active study participation and 1 year of follow-up
Neuronal and Behavioral Effects of an Implicit Priming Approach to Improve Eating Behaviors in Obesity
Study volunteers will be asked to complete an MRI scan, during which they will watch pictures of foods. Participants will also complete a 12-week intervention that involves viewing food or food images, with once-weekly study visits. After the intervention, we will ask volunteers to complete another MRI scan. During the study, volunteers will also complete questionnaires about food, eating, or mood, and will have their body composition measured.
Cannabinoids and Traumatic Brain Injury: A Randomized, Placebo Controlled Trial
The LUNA study will longitudinally follow 120 individuals 18-60 years with mild to moderate TBI for 12 weeks who are willing to use hemp-derived CBD products. This is a double-blind, placebo-controlled, randomized controlled trial (RCT), such that both the researchers conducting the study condition assignment and clinical assessments and the participant are blind to the condition. We will randomly assign individuals with mild to moderate TBI to either hemp-derived full-spectrum CBD (FS-CBD), which contains low levels of other cannabinoids, CBD alone (CBD), or placebo in a 12-week RCT with measurement of critical indicators occurring at baseline, 6 weeks post-baseline and 12 weeks post-baseline. The dose of CBD in the FS-CBD and CBD conditions is 210mg. We will monitor the participant's TBI symptoms while on study medication.
Youth and Young Adult PrEP Study
Did you know that youth and young adults represent the largest proportion of new HIV diagnoses in Colorado? You can help us learn how to prevent HIV among Colorado Youth by getting started on PrEP, the medicine that prevents HIV.
Pathophysiology of Active and Latent Myofascial Trigger Points
We are seeking male volunteers for a research study on tension headache and muscle physiology.
You may be eligible if you:
You may be eligible if you:
- Male
- Have or do not have regular tension headaches
- Are generally healthy with no history of fibromyalgia, diabetes, or bleeding disorders
- Aged 18-59
A Randomized Parallel Comparison of Semaglutide versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus
Volunteers are needed for a research study examining the effects of once weekly semaglutide on intestinal barrier function in type 2 diabetics who are being treated with metformin only. Main procedures involve blood draws, lactulose mannitol ratio (urine) test, stool samples, and once-weekly subcutaneous injection of either semaglutide or a placebo. Compensation will be provided.
How do I feature a study?
If you would like to have your study featured please submit your information and we will work on including your study information in our next issue.
Research Admin Communications